NEW YORK (GenomeWeb News) – Analytik Jena said today it has acquired all the assets of SIRS-Lab, a developer of molecular diagnostics for infectious diseases, which declared insolvency in December and had been seeking an investor to commercialize its lead product, a test for sepsis.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.